Expertise

  • Our mission is…

    To enable reliable and ethical drug releases thus reducing unnecessary animal-based testing.

    MAT-Biotech offers reliable, quantitative, nonanimal-based pyrogen testing solutions using the Monocyte Activation Test of CTL-MAT.

    Our products and services permit Ph. Eur. 2.6.30-compliant, robust and accurate detection of pyrogenic contaminants in parenteral drugs, biopharmaceuticals, cosmetics and solid medical devices.

    MAT-Biotech can support its customers with all their MAT related needs.

    Contact us

  • Expertise

    MAT Biotech was founded by Drs. Shabnam Solati
    She has over 14 years of Monocyte Activation Test experience with both the scientific and regulatory aspects of the technology and developed the CTL-MAT in collaboration with Prof. Dr. Paul Lehman (CEO of Cellular Technology Limited). Shabnam is also the CEO of CTL-MAT (Cleveland OHIO, US, www.ctl-mat.com). CTL-MAT, combines CTL’s background in immune monitoring with Drs. Solati’s MAT specific expertise to support the global adaption of the Monocyte Activation Test.

    Cellular Technology Limited has been the pioneer and industry leader in the development, use, and manufacturing of standardized tools for cellular immune assays. CTL’s founding scientists were the first to introduce protocols for functionality loss free cryopreservation of PBMC (patent). For over 20 years, CTL has been a leading provider of cryopreserved PBMC and cytokine detection kits.

    Dr. Henk Viëtor is managing director of MAT-Biotech has been active in the life sciences industry for 20 years. During this time, he founded 25 star-up companies in diagnostics, drug development, medical devices and consultancy services.

  • What We Do

    MAT Biotech offers products and services for the complete integration of the Monocyte Activation Test. The MAT permits European Pharmacopoeia 2.6.30 compliant, robust and accurate detection of pyrogenic contaminants of parenteral drugs, biopharmaceuticals and solid medical devices.

    MAT Biotech’s mission is to enable reliable and ethical drug releases thus reducing unnecessary animal-based testing

MAT BioTech B.V. | Hollandse Kade 32-33 | 1391 JM Abcoude | The Netherlands
Phone: +31 (0)255-220900 | Fax: +31 (0)255-220901 | Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us

MAT BioTech 2019
All Rights Reserved - Privacy Statement